7-Bromo-6,8-difluoroquinazoline-2,4(1H,3H)-dione, 98%, 5g

2-Amino-2-propylpentanoic acid, 95.0%, 25g

IR-813 p-Toluenesulfonate>98.0%(HPLC)1g

Benzyl 4-carbamothioylpiperidine-1-carboxylate, 95.0%, 1g

1-(7-Methoxy-4-methylquinazolin-2-yl)guanidine, 98.0%, 250mg

5,8-Dibromo[1,2,4]triazolo[1,5-a]pyrazine, 1g

bScope BS.1153-EPLPH for phase contrast. Triocular with HWF 10x/20 mm eyepieces and Quadruple revolver E-plan Phase 10/20/S40 S100x

Azelaic Acid>98.0%(GC)(T)250g

N-(2-acetylphenyl)acetamide, 98%, 25g

(2S,4R)-1-(tert-Butoxycarbonyl)-4-fluoro-2-pyrrolidinecarboxylic Acid>96.0%(GC)(T)200mg

(R)-4-Isopropyl-5,5-diphenyloxazolidin-2-one, 95.0%, 5g

Ethyl 4-hydroxyphenylacetate, 96.0%, 1g

ETHYL 6-CHLOROISOQUINOLINE-3-CARBOXYLATE, 95%, 250mg